Advanced search
Publication Cover
Journal of Biopharmaceutical Statistics Volume 29, 2019 - Issue 4: Special Issue: Real Word Experience and Randomized Clinical Trials
Submit an article Journal homepage
348
Views
6
CrossRef citations to date
0
Altmetric
Articles

Commentary on “Applying CHW method to 2-in-1 design: gain or lose”

Lu CuiData Statistical Science, AbbVie Inc., North Chicago, IL, USACorrespondence[email protected]
,
H.M. James HungDivision of Biometrics I, OB/OTS/CDER, FDA, Silver Spring, MD, USA
&
Sue Jane WangOffice of Biostatistics, OTS/CDER, FDA, Silver Spring, MD, USA
Pages 722-727 | Received 30 Jan 2019, Accepted 18 Mar 2019, Published online: 29 Jun 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xuekui Zhang, Haijun Jia, Li Xing & Cong Chen. (2023) Application of Group Sequential Methods to the 2-in-1 Design and Its Extensions for Interim Monitoring. Statistics in Biopharmaceutical Research 0:0, pages 1-10.
Read now

Articles from other publishers (5)

Wen Li, Heng Zhou, Calvin Jia & Linda Sun. (2022) Family-wise type I error rate control for an extended 2-in-1 design with graphical approach in oncology drug development. Contemporary Clinical Trials 119, pages 106846.
Crossref
Wen Li, Xiaofei Bai, Qiqi Deng, Fang Liu & Cong Chen. (2021) Estimation of treatment effect in 2‐in‐1 adaptive design and some of its extensions. Statistics in Medicine 40:11, pages 2556-2577.
Crossref
Yi Liu & Heng Xu. (2021) Sample size re-estimation for pivotal clinical trials. Contemporary Clinical Trials 102, pages 106215.
Crossref
Li Fan, Jing Zhao & Wen Li. (2020) The extension of 2-in-1 adaptive phase 2/3 designs and its application in oncology clinical trials. Contemporary Clinical Trials 98, pages 106148.
Crossref
Cong Chen, Wen Li & Qiqi Deng. (2020) Extensions of the 2-in-1 adaptive design. Contemporary Clinical Trials 95, pages 106053.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.